Suscribete

CRI and Mark Foundation Launch ctDNA Clinical Trial

The Phase 2 clinical trial will analyze blood-based biomarkers versus conventional radiography for cancer patients treated with...

CRI Statement on Blackbaud Data Breach

The Cancer Research Institute (CRI) was informed on July 16, 2020, that one of our vendors, Blackbaud, experienced a data...

Eighth Annual Cancer Immunotherapy Month™

30 days of immunotherapy education and awareness programming for patients, caregivers, and the others celebrating advances in...

Rapid Growth in Cancer Cellular Immunotherapies

Report reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development...

Impact of COVID-19 on Oncology Clinical Trials

Results of recent survey of clinical trial investigators in United States, Europe, and Asia together with analysis...

Steven A. Rosenberg Recognized With 2020 AACR-CRI Lloyd J. Old Award

The American Association for Cancer Research (AACR) will present Steven A. Rosenberg, MD, PhD, Fellow of the...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.